Primary Site >> Colorectal Cancer

Gene >> PSMD4

Journal: Oncogene. 2009 Nov 12;28(45):3983-96.
Title: Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).
Author: Arlt, A|Bauer, I|Schafmayer, C|Tepel, J|Muerkoster, S Sebens|Brosch, M|Roder, C|Kalthoff, H|Hampe, J|Moyer, M P|Folsch, U R|Schafer, H
PMID: 19734940
Journal: Free Radic Biol Med. 2016 Jun;95:121-32.
Title: Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4.
Author: Lin, Po-Lin|Chang, Jinghua Tsai|Wu, De-Wei|Huang, Chi-Chou|Lee, Huei
PMID: 27033953
Journal: Inflamm Bowel Dis. 2016 Nov;22(11):2593-2606.
Title: Colonic Lamina Propria Inflammatory Cells from Patients with IBD Induce the Nuclear Factor-E2 Related Factor-2 Thereby Leading to Greater Proteasome Activity and Apoptosis Protection in Human Colonocytes.
Author: Kruse, Marie-Luise|Friedrich, Martin|Arlt, Alexander|Rocken, Christoph|Egberts, Jan-Hendrik|Sebens, Susanne|Schafer, Heiner
PMID: 27661668
Journal: Oncotarget. 2018 May 29;9(41):26342-26352.
Title: PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2.
Author: Cheng, Ya-Min|Lin, Po-Lin|Wu, De-Wei|Wang, Lee|Huang, Chi-Chou|Lee, Huei
PMID: 29899863